Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2009-10-19
pubmed:abstractText
Treatment of base of tongue (BOT) squamous cell carcinoma (SCC) has traditionally been associated with poor prognosis and significant morbidity. We report a program consisting of concurrent chemoradiation followed by brachytherapy for these patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1097-0347
pubmed:author
pubmed:copyrightInfo
(c) 2009 Wiley Periodicals, Inc. Head Neck, 2009.
pubmed:issnType
Electronic
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1431-8
pubmed:meshHeading
pubmed-meshheading:19405086-Adult, pubmed-meshheading:19405086-Aged, pubmed-meshheading:19405086-Aged, 80 and over, pubmed-meshheading:19405086-Antineoplastic Agents, pubmed-meshheading:19405086-Brachytherapy, pubmed-meshheading:19405086-Carboplatin, pubmed-meshheading:19405086-Carcinoma, Squamous Cell, pubmed-meshheading:19405086-Chemotherapy, Adjuvant, pubmed-meshheading:19405086-Cisplatin, pubmed-meshheading:19405086-Cohort Studies, pubmed-meshheading:19405086-Disease-Free Survival, pubmed-meshheading:19405086-Female, pubmed-meshheading:19405086-Fluorouracil, pubmed-meshheading:19405086-Humans, pubmed-meshheading:19405086-Male, pubmed-meshheading:19405086-Middle Aged, pubmed-meshheading:19405086-Paclitaxel, pubmed-meshheading:19405086-Radiation-Sensitizing Agents, pubmed-meshheading:19405086-Retrospective Studies, pubmed-meshheading:19405086-Tongue Neoplasms, pubmed-meshheading:19405086-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Management of squamous cell carcinoma of the base of tongue with chemoradiation and brachytherapy.
pubmed:affiliation
Department of Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA.
pubmed:publicationType
Journal Article